RIA Member – Cure Leukaemia
With a new blood cancer diagnosis every 27 seconds worldwide, Cure Leukaemia funds specialist research nurses and clinical roles at blood cancer centres across the UK, providing patients with access to innovative and potentially life-saving treatments through clinical trials. By supporting these roles, Cure Leukaemia facilitates potentially life-saving advancements in blood cancer therapies nationally but also contributes to global progress and hope for those impacted by the disease worldwide.
In 2024, The ATICUS Network was announced, forming a pioneering collaboration between 11 leading UK Children’s Hospitals to revolutionise clinical transplant trial access for children battling blood cancer.